Trial Profile
Efficacy and safety of telaprevir-based triple therapy for patients aged 66 years and older with genotype 1b chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 31 Aug 2015 New trial record